Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
117M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$381M
-
Value change
-
+$29.1M
-
Put/Call ratio
-
0
-
Number of buys
-
42
-
Number of sells
-
-33
-
Price
-
$21.23
Significant Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q1 2016
91 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share as of Q1 2016.
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 117M outstanding shares and own 15.36% of the company stock.
Largest 10 shareholders include FMR LLC (5.87M shares), JPMORGAN CHASE & CO (2.12M shares), RA CAPITAL MANAGEMENT, LLC (1.27M shares), BlackRock Fund Advisors (1.12M shares), TIAA CREF INVESTMENT MANAGEMENT LLC (719K shares), VANGUARD GROUP INC (656K shares), VHCP Management, LLC (611K shares), Cormorant Asset Management, LLC (569K shares), AXA (449K shares), and BlackRock Institutional Trust Company, N.A. (390K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.